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Virtually all known chemicals can
cause injury or death, depending
on the dose of the substance. The
lethal dose may vary widely. For
example, 4 000 mg/kg of table salt
will be lethal to 50% of a popula-
tion of experimental animals
(expressed as the LD50), while the
LD50 of arsenic trioxide is 1 - 2
mg/kg, and that of botulinum toxin
0.00001 mg/kg. A number of fac-
tors may contribute to toxicity:
physico-chemical characteristics
such as the pKa, lipid solubility,
the route of entry (e.g. orally or
percutaneously), the nature of the
exposure (e.g. acute or chronic)
and the susceptibility of the victim.
This refers to factors such as the
state of fetal development, child-
hood, advancing age and underly-
ing pathology. In addition, the
vehicle in which the agent is dis-
solved or suspended, and other
formulation factors, may markedly
influence toxicity. There is no
entirely ‘safe’ chemical since all
have the potential to cause death
and injury under specific circum-
stances. It should also be empha-
sised that some adverse reactions
to chemicals, such as allergic and
idiosyncratic reactions, are not
dose-related.1,2
In practice the critical factor is not
whether or not a substance is poi-
sonous, but whether someone is at
risk from exposure to it. Risk is
the probability that a substance
will cause harm under specified
conditions. This is reflected in a
hazard rating on a scale of 1 - 3,
where 3 indicates a high hazard
rating (LD50 < 400 mg/kg), 2 is
intermediate (LD50 of 400 - 4 000
mg/kg), and 1 is low (LD50 of
4 000 - 40 000 mg/kg). Safety, the
opposite of risk, is the probability
that harm will not occur under
specified conditions.2,3
‘Non-toxic ingestion’ refers to the
consumption of a non-edible agent
or product usually not associated
with harmful effects. The practical
value of knowing that a product is
‘usually non-toxic’ prevents:
• an inappropriate response that
causes panic 
• over-treatment of the patient
• unnecessary visits to the doctor
or hospital emergency facility.4
For an agent to be considered
‘usually non-toxic’, it should meet
the following criteria:
• positive identification of the
product, its ingredients, and its
concentration 
• positive assurance that it was
the only product ingested.1,4
Because of unpleasant or disagree-
able tastes, the quantity of  ‘non-
edible’ substances ingested acci-
dentally is usually small. The aver-
age quantity of liquids swallowed
accidentally by a child under the
age of 5 years is 5 ml, and that by
an adult 15 ml. In contrast, the
quantity swallowed intentionally
(by adults) is usually considerably
larger, and should be taken into
consideration when potential haz-
ard or risk is assessed.
Table I lists the most frequently
ingested household agents consid-
ered ‘usually non-toxic’. This table
is intended as a guide only, and
should be used in conjunction with
the information given above.4,5
For clinical purposes, poisons
(including therapeutic drugs) may
be divided into two broad cate-
gories:
• Poisons (and their metabo-
lites) which directly cause
irreversible or slowly
reversible structural or 
functional tissue damage in
one or more organ systems.
These are also considered com-
pounds with a high inherent
toxicity (Table II). Arsenic and
the organophosphates are good
examples of poisons which may
cause irreversible damage, long-
lasting (slowly reversible) organ
dysfunction, or lead to compli-
cations which may require
extended periods of supportive
therapy. Significant symptoms
and signs of a substantial num-
ber of poisons in this group may
appear late (1 - 3 days post
Diagnosis of acute poisoning
As all chemicals can act as poisons in the right quantity, 
effective lines of communication between the attending 
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stance.
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exposure). At this stage symp-
toms may not be expected, or
the incident may have been par-
tially forgotten. This can mean
that the patient and/or doctor
may not immediately (if at all)
associate the cause of the symp-
toms with exposure, leading to
delayed optimal therapeutic
intervention. Examples include
paracetamol and Amanita phal-
loides poisoning.
• Poisons which do not cause
tissue damage directly or
which cause toxic effects
which are rapidly and com-
pletely reversible. Although
many agents in this category
have the potential to cause 
serious organ dysfunction or
even death, appropriate support-
ive care during the acute phase
will ensure complete recovery in
most instances. Fortunately,
most potential poisons dealt
with in the clinical setting fall
into this category. Consequently,
most poisoned patients require
treatment of symptoms and
appropriate supportive care
only. ‘Supportive care’ is the
maintenance of normal respira-
tory, circulatory and renal func-
tion with monitoring of blood
gases, acid/base balance, serum
electrolyte and glucose levels,
etc. Benzodiazepines and opi-
ates taken in overdose, and even
strychnine, are examples of poi-
sons with a relatively low inher-
ent toxicity.
When dealing with a suspected
case of  poisoning, one of the main
priorities should be to attempt to
identify poisons with a high inher-
ent toxicity as soon as possible
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Drug or poison Specific treatment† Reason for early antidotal/
active removal therapy
Carbon monoxide‡ Oxygen Tissue damage (nervous system)
Cyanide‡, § Oxygen. In serious poisoning: Extremely toxic, often with a morbid course and 
sodium nitrite/sodium thiosulphate death
or Kelocyanor (Restan)
Digoxin Digoxin-specific antibodies With massive overdose poisoned membranes 
can no longer maintain electrolyte gradients; this
leads to extremely high potassium levels
Ethylene glycol‡, ¶ Ethanol, haemodialysis Tissue damage (nervous system, kidney)
Isoniazid‡ Pyridoxine, haemodialysis Tissue damage (nervous system)
Lithium carbonate** Haemodialysis Tissue damage (nervous system, kidney)
Metals and metalloids
Arsenic** Dimercaprol, penicillamine Tissue damage (nervous system, liver, kidney)
Tissue damage (gastrointestinal, liver, CVS)
Iron‡, ** Deferoxamine Tissue damage (nervous system)
Lead** Dimercaprol, calcium disodium Tissue damage (nervous system, kidney)
edetate
Mercury** Dimercaprol, penicillamine
Methanol‡, ¶ Ethanol, haemodialysis Tissue damage (nervous system, blindness)
Methyl bromide Dimercaprol, N-acetylcysteine Tissue damage (nervous system, CVS, kidneys)
Mushrooms —
cyclopeptides as in Silibinin Tissue damage (liver, kidney, heart, pancreas)
Amanita phalloides**
Organophosphates** Obidoxime chloride, atropine To prevent extended periods of intensive care
Paracetamol N-acetylcysteine Tissue damage (liver, kidney)
Paraquat (diquat)**, †† Immediate, aggressive Multisystem failure (kidney, liver, nervous
decontamination procedures plus system, heart, lungs)
activated charcoal or a watery slurry
of clay
Salicylates‡ Haemodialysis Tissue damage (nervous system)
Theophylline‡, ** Haemoperfusion Tissue damage (nervous system)
*Examples are those in which antidotes or special toxin removal procedures may prevent permanent tissue damage or serious complications (paraquat and carbon monoxide
excluded).
†The degree of poisoning, together with drug or poison levels, usually determines the specific treatment regimen.
‡Causes marked metabolic acidosis.
§Included because of its potential to cause death within minutes. Most patients who recover have no permanent sequelae.
¶Causes alterations in the osmolar gap.
**Gastrointestinal disturbances prominent.
††Survival only possible if oral activated charcoal or a watery slurry of clay combined with a cathartic (preferably magnesium sulphate or sorbitol), is given as soon as possible
to prevent absorption. Once absorbed it is doubtful whether an antidote or special toxin removal procedure will prevent tissue damage.
Table II. Examples of drugs and poisons with a high inherent toxicity*
(Table II). This allows timely anti-
dotal or special decontamination
procedures so that severe tissue
damage and complications can be
avoided. Agents with a low inher-
ent toxicity need to be identified
early where the use of a specific
antidote may avoid relatively risky
treatment regimens. An example is
the treatment of an opiate overdose
with naloxone, rather than with
mechanical ventilation, which may
predispose to respiratory infection
and other complications.5,6
GUIDELINES FOR EARLY
IDENTIFICATION OF A 
POISON
History
While vital functions are being
assessed/stabilised, a proper history
should be obtained. Important
information includes the nature of
the poison, degree of exposure and
time since exposure. Since it is
often difficult to obtain a reliable
history from the poisoned patient
(up to 50% of histories are incor-
rect as to the substance, quantity
or even actual exposure), the clini-
cian must rely on a high index of
suspicion and be aware of the tox-
ins that possess a high inherent
toxicity (Table II). Communi-
cation with family, friends, tradi-
tional healers, general practitioners
and local pharmacists may provide
useful information. Relatives or
friends should be asked not to
leave the premises until the clini-
cian has had the opportunity to
question them. A special effort
should be made to obtain speci-
mens and containers involved.
Clinical evaluation/physical
examination
Symptoms and signs provide valu-
able clues to the causative toxic
agent. Although manifestations of
acute poisoning may be wide and
varied, patients who have ingested
poisons with high inherent tissue-
damaging potential often present
with severe and persistent gastroin-
testinal symptoms and signs 
(Table II). Hypotension, cardiac
dysrhythmias, seizures, acid-base
and electrolyte disturbances (aci-
dosis and hyperkalaemia), and
signs of liver and renal impairment
usually also indicate serious poi-
soning.
Although the diagnosis of acute
poisoning can seldom be made on
the basis of a single symptom or
sign, specific poisonings are associ-
ated with clusters of clinical fea-
tures which may be of diagnostic
value. In the context of a condi-
tion caused by a poisonous sub-
stance, a set of associated symp-
toms and signs is referred to as a
toxidrome. Toxidromes may be
useful when attempting to identify
the cause of a poison-induced
symptom/sign complex. An exam-
ple in point is the association of a
garlicky smell on the breath with
vomiting, profuse bloody diar-
rhoea, delayed hair loss and dis-
tinctive lines in nails, which is
pathognomic of arsenic poisoning.
Toxidromes and their causes are
listed in the introductory chapters
of most standard toxicology text-
books. A given toxidrome, howev-
er, must be interpreted with cau-
tion since it may not be specific,
and hence pathognomonic, but
may apply to more than one poiso-
nous agent and may even be mim-
icked by a disease state unrelated
to poisoning. Although toxidromes
are useful when dealing with an
unidentified toxic agent, they may
be misleading and their use fraught
with pitfalls for the unwary and
inexperienced.
Central nervous system (CNS)7
CNS depression is one of the most
common manifestations of acute
poisoning. Substances usually
implicated include alcohol, anti-
convulsants, benzodiazepines, tri-
cyclic antidepressants, organophos-
phates, carbamates and salicylates.
A combination of alcohol with
other CNS depressants is particu-
larly hazardous.
• Lateralising neurological
signs. With the exception of
transient inequality of pupil size,
lateralising neurological signs
effectively exclude a diagnosis of
acute poisoning unless the signs
are due to a pre-existing condi-
tion.
• Pyramidal tract signs. An
overdose of tricyclic antidepres-
sant agents, and the earlier gen-
erations of antihistamines with
prominent anticholinergic prop-
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erties, often induces hypertonia,
hyperreflexia and extensor plan-
tar responses.
• Extrapyramidal signs. An
overdose of metoclopramide, a
phenothiazine or a butyrophe-
none antipsychotic agent, may
induce an acute dystonic reac-
tion. Dystonia also often occurs
in association with carbon
monoxide poisoning.
• Seizures. Compounds usually
implicated include camphorated
oil, chlorinated hydrocarbons
(e.g. gamma benzene hexachlo-
ride), organophosphates and the
carbamates. Medicinal agents
include carbamazepine, the sali-
cylates (aspirin and mefenamic
acid), the tricyclic antidepres-
sants, theophylline, carbon




dose with agents such as
ethanol, tricyclic antidepres-
sants, theophylline and carba-
mazepine is known to cause agi-
tation. Other causes, such as
hypoxia, should always first be
excluded.
• Pupils. The opioids, cholin-
esterase inhibitors, barbiturates,
chloral hydrate, pilocarpine and
the phenothiazines often induce
miosis. In contrast, the
antimuscarinic and sympath-
omimetic agents, the tricyclic
antidepressants, carbamazepine
and diphenhydramine, among
others, often cause mydriasis.
Non-medicinal chemicals that
may induce dilated pupils
include ethanol, methanol, LSD,
cocaine, cyanide and certain
neurotoxic snake venoms.
• Anosmia. Loss of the sense of

















and, frequently, tricyclic antide-
pressants (sympathomimetic
and antimuscarinic effects) may
be implicated.
• Hypotension. Tricyclic antide-
pressants ( -blocking effects),
antipsychotic drugs, -blocking
agents, barbiturates, and central-
acting antihypertensive drugs
may be implicated.













Blisters on the skin are occasionally
found in poisoned patients and are
associated with a wide variety of
drug overdoses, but especially with
phenobarbitone overdose. A dry,
hot, flushed skin is typical of
atropine poisoning. Heavy perspi-
ration is common in organophos-
phate poisoning and in latrodec-
tism.
Absence of clinical signs of toxicity 
In poisoning with certain sub-
stances, the onset of toxic manifes-
tations may be delayed. During
this latent period clinical evalua-
tion will reveal no clear abnormal
findings. Symptoms and signs of
poisoning with Amanita phalloides
mushrooms, methyl bromide,
organophosphates, paracetamol,
and the superwarfarin rodenticides,
may not immediately be evident
and may be delayed for varying




A sample of the suspected toxic
substance or the material ingested
is crucial for rapid and positive
identification of a poison.
Identification can often be
achieved by simple inspection.
Health care providers should be
encouraged to collect, inspect and
send the suspected toxic material
to the laboratory as soon as possi-
ble. If the suspected toxic sub-
stance is not initially brought in
with the patient, a special effort
should be made to send family or
friends, or even the police, to col-
lect specimens and containers.
Obtaining the original toxic sub-
stance or container is more valu-
able and reliable for rapid and pos-
itive identification of a poison than
depending on laboratory analysis
of blood, urine or other body flu-
ids.5
The toxicology laboratory 
Laboratory analyses play an impor-
tant role in the identification or
exclusion of poisons. In addition,
the laboratory may be able to assist
in quantifying the severity of expo-
sure. Because of time limitations,
expense, and the large number
(thousands) of potentially toxic
substances commonly encoun-
tered, standard toxicology screen-
ing procedures cannot cover all the
possibilities. Contrary to the per-
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A dry, hot, flushed
skin is typical of
atropine poisoning.
ceptions of most clinicians, routine
toxicology screening tests are pri-
marily designed to identify, or
eliminate, a limited number of
drugs and non-drug chemicals
which are commonly involved in
poisoning. If none of the com-
pounds for which the tests were
designed are identified, the test is
reported as being negative. Con-
sequently, a negative screening test
does not imply that poisoning has
not occurred but only that the
compounds tested for are not the
culprits. In the normal course of
events fewer than 50 compounds
are routinely screened for. There-
fore, the use of a toxicology screen
without an understanding of its
possibilities and limitations may be
misleading or even hazardous. If
the screen is negative, but a diag-
nosis of poisoning cannot be
excluded clinically, the toxicologist
should be consulted for an opinion
on appropriate additional special
investigations and/or an appropri-
ate course of action. It needs to be
stressed that when a medical emer-
gency is thought to be the result of
an unidentified poison, efforts
should be directed at identification
or elimination of those agents with
high inherent toxicity.5
Effective lines of communication
between the attending clinician or
health worker, the laboratory and
the toxicologist are essential.
Quantitative determination of tox-
ins is needed for relatively few sub-
stances, e.g. paracetamol, salicy-
lates, theophylline, lithium, digoxin
and metals. For some of these,
depending on the elimination rate
of the substance, two plasma levels
some hours apart may be needed
to determine whether concentra-
tions are rising or falling, before
deciding if a specific therapy is
needed or can be discontinued.
Non-toxicological investiga-
tions
In most cases of poisoning, stan-
dard special investigations, such as
serum electrolyte, glucose, arterial
blood gases, blood urea nitrogen,
the ion and osmolal gap measure-
ments, as well as liver and kidney
function tests, full blood count,
clotting profile (prothrombin time
and INR), urinalysis and ECG, are
often more rewarding for diagnos-
tic purposes than a toxicology
screen.
• Urine. Brown discolouration of
urine may be due to the pres-
ence of haemoglobin (due to
intravascular haemolysis), myo-
globin secondary to rhabdomy-
olysis (see later) or metabolites
of paracetamol. Urinary oxalate
crystals are a common, but not
invariable, feature of ethylene
glycol intoxication.
• Clotting profile. Prolongation
of the prothrombin time or the
INR may be caused either by
ingestion of vitamin K antago-
nists (e.g. super warfarin rat poi-
sons), or by liver necrosis sec-
ondary to paracetamol or hepa-
totoxic mushroom poisoning,
among others. A prolonged
clotting time may be indicative
of boomslang bite.
• Hypoglycaemia. Low glucose
concentrations may be due to an
overdose of oral antidiabetic
agents (e.g. sulphonylureas) or
insulin. It may also be a com-
plication of severe paracetamol
or Amanita phalloides (hepato-
toxic mushroom) poisoning.
• Hyperglycaemia is often asso-
ciated with an overdose of sym-
pathomimetic agents or theo-
phylline.
• Liver function abnormalities.
Abnormalities, with or without
jaundice, are common with
advanced paracetamol, arsenic
or hepatotoxic mushroom (e.g.
Amanita phalloides) poisoning.
• Nephrotoxicity. Acute renal
failure may occur in aminogly-
coside, heavy metal, arsenic and
ethylene glycol poisoning.
Poisons that cause rhabdomyo-
lysis with myoglobinuria (many
poisons) may indirectly cause
renal failure.
• Hypocalcaemia. Low calcium
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In most cases of
poisoning, standard
special investiga-





levels are a complication of fluo-
ride and ethylene glycol poison-
ing.
• ECG abnormalities. A num-
ber of toxins induce well-recog-
nised ECG changes that are, to
a greater or lesser extent, specif-
ic and may confirm, or cast
doubt on, the compound or
substance thought to be
involved. These changes include
a prolonged QT interval (e.g.
phenothiazines), a widened QRS
interval (e.g. tricyclic antide-
pressants and quinidine), atrio-
ventricular conduction block
(e.g. digoxin, tricyclic antide-
pressants and phenytoin) and
ventricular arrhythmias (e.g. tri-
cyclic antidepressants, digoxin
and theophylline).7
• Water, electrolyte and acid-
base disturbances are com-
mon complications of acute poi-
soning and this topic is dis-
cussed in the article on p. 466.
IMPORTANT CLINICAL




This syndrome may be caused by
drugs, or combinations of drugs,
which increase serotonin activity in
the brain. It usually occurs when
two or more drugs, which increase
serotonin availability by different
mechanisms, are used simultane-
ously. It is a syndrome that pre-
sents with at least 3 of the follow-
ing features: altered mental status
(confusion, hypomania), agitation,
myoclonus, hyperreflexia, sweating,
shivering, tremor, diarrhoea, inco-
ordination, and fever. The syn-
drome may be difficult to distin-
guish from the neuroleptic malig-
nant syndrome. Hyperthermia is a
characteristic finding. Tachycardia,
hypertension and tachypnoea are
common. Hypotension and respi-
ratory failure, and even a DIC,
may develop in severe cases. The
creatine kinase (CK) levels are
usually elevated. Patients being
treated with antidepressant agents
who take drugs of abuse, such as
the amphetamines and cocaine, are
particularly vulnerable. This syn-
drome is often a complication of
drug abuse in the ‘rave’ party set-
ting.8
Rhabdomyolysis
This is a syndrome resulting from
skeletal muscle damage, with
release of muscle cell contents into
the plasma (myoglobinaemia),
manifesting as myoglobinuria.
Renal failure can occur secondary
to rhabdomyolysis. Common
causes of rhabdomyolysis include
drug abuse/overdose and alcohol
abuse, or following trauma,
seizures, and infections. Although
alcohol and drug abuse/overdose
are implicated in many cases, the
actual rhabdomyolysis may be due
to secondary causes, such as
seizures, trauma, metabolic acido-
sis, hypoxia, coma, immobilisation,
muscle compression, or occlusion
of the regional blood supply. Beta-
receptor stimulation and hyperdy-
namic states, such as malignant
hyperthermia, neuroleptic malig-
nant syndrome, and hypokalaemia
have been documented to cause
rhabdomyolysis, as well as pro-
longed physical activity, agitation,
and compartment syndrome.
References available on request.
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IN A NUTSHELL
When dealing with a suspect-
ed toxic exposure or poison-
ing, one of the major priorities
should be to attempt to identi-
fy agents with a high inherent
toxicity as soon as possible.
Early identification will allow
timeous antidotal or special
decontamination procedures
so that severe tissue damage
or complications can be avoid-
ed.
Patients who have ingested
poisons with a high inherent
tissue-damaging potential
often present with severe and
persistent gastrointestinal
symptoms and signs.
The suspected toxic substance
or the material ingested is cru-
cial for rapid and positive iden-
tification of a poison.
